Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Gazit-Globe Takes Over Atrium

Gazit-Globe

Israel’s largest real estate investment firm, Gazit-Globe, has become the controlling shareholder in Atrium European Real Estate Limited. It now has a 55% stake in the company after acquiring an additional 52, 069, 622 of its ordinary shares representing approximately 13.87% of ATR’s issued share capital and voting rights. The shares were bought for EUR 4.40 ($5.20) per
share.

Roni Soffer, President of Gazit-Globe, stated, “Gazit-Globe’s acquisition of the remaining Atrium shares held by CPI at an attractive price relative to NAV per share is the realization of a rare opportunity to become the sole controlling shareholder of Atrium. This acquisition is in line with our global strategy to be the controlling shareholder of real estate companies with
great management teams, strong balance sheets, and investment grade credit ratings that specialize in supermarket-anchored shopping centers operating in urban growth markets with high investment grade credit ratings.”

Soffer added, “I want to thank CPI’s management for their long-standing, successful partnership in improving Atrium, which, due to the leadership of its excellent management team, has become the leading player in Central Europe. We look forward to continue to accompany Atrium along its current successful course.”

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Advertisement
cialis